Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Educational materials in the global toolkit including facilitator and participant guides, infographics and videos focus on helping clinicians integrate SGLT2 inhibitors into HF therapy as part of guideline-directed medical therapy
Duncan, Jessica, et al
Conflicts of interest Nothing to report
At a 70% price reduction, GLP-1RA is predicted to be cost-effective compared to non-SGLT2i standard-of-care therapies (cost-effectiveness ratio [CER] of $22,700)
US$ 22.18
US$ 25.57
US$ 20.56
US$ 26.64
US$ 23.27
US$ 20.17
